Epstein-Barr virus persistence and reactivation in neuromyelitis optica.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 25433035)

Published in J Neurol Neurosurg Psychiatry on November 28, 2014

Authors

Saeko Masuda1, Masahiro Mori1, Kimihito Arai2, Akiyuki Uzawa1, Mayumi Muto1, Tomohiko Uchida1, Hiroki Masuda1, Satoshi Kuwabara1

Author Affiliations

1: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
2: Department of Neurology, National Hospital Organization Chiba-East-Hospital, Chiba, Japan.

Articles by these authors

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2020) 3.93

Isolated transient myoclonus in the elderly: an under-recognized condition? Clin Neurol Neurosurg (2013) 2.04

First adult case of Helicobacter cinaedi meningitis. J Neurol Sci (2013) 0.91

Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve (2015) 0.89

Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2014) 0.87

Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2015) 0.87

Guillain-Barré syndrome in Asia. J Neurol Neurosurg Psychiatry (2013) 0.84

Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler (2015) 0.83

Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging (2015) 0.82

Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open (2015) 0.82

Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci (2015) 0.81

Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? Case Rep Neurol (2014) 0.79

Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry (2015) 0.78

Serum high mobility group box 1 is upregulated in myasthenia gravis. J Neurol Neurosurg Psychiatry (2014) 0.78

Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. J Neurol Sci (2015) 0.78

Incidental diagnosis of an asymptomatic adult-onset Alexander disease by brain magnetic resonance imaging for preoperative evaluation. J Neurol Sci (2015) 0.77

Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. PLoS One (2014) 0.77

Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler (2016) 0.76

Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited. J Neuroimmunol (2014) 0.76

Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry (2016) 0.76

Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2016) 0.76

Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? J Neurol Neurosurg Psychiatry (2014) 0.75

Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75

Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies. J Neurol Neurosurg Psychiatry (2015) 0.75

A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics (2016) 0.75

Reply to letter to the Editor: isolated transient myoclonus in the elderly. Clin Neurol Neurosurg (2014) 0.75

Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. PLoS One (2015) 0.75

Corticosteroid-responsive leptomeningitis with IgG4-positive plasma-cell infiltration. J Neurol Sci (2015) 0.75

A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry (2016) 0.75

Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. J Neurol Sci (2015) 0.75

Muscle haematoma due to antithrombotic treatment for ischaemic stroke. J Clin Neurosci (2015) 0.75

Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci (2016) 0.75

Vogt-Koyanagi-Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels. Clin Neurol Neurosurg (2014) 0.75

[Neurophysiologic assessment of disorders affecting the neuromuscular junction]. Brain Nerve (2011) 0.75

Brain gray matter structural network in myotonic dystrophy type 1. PLoS One (2017) 0.75

Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry (2017) 0.75

A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Clin Neurol Neurosurg (2013) 0.75

Benign neuromyelitis optica is rare in Japanese patients. Mult Scler (2014) 0.75

Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation. J Neurol Sci (2017) 0.75

Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy. J Neurol (2017) 0.75

The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement. J Neuroimmunol (2019) 0.75

Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry (2017) 0.75

Rapidly progressive Aspergillus meningitis successfully treated with voriconazole and corticosteroids. Neurol Sci (2017) 0.75

Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J Neuroimmunol (2015) 0.75

Pneumocephalus associated with Pott's puffy tumor. J Neurol Sci (2016) 0.75

Pain-related evoked potentials after intraepidermal electrical stimulation to Aδ and C fibers in patients with neuropathic pain. Neurosci Res (2017) 0.75

Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS One (2017) 0.75

Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity. J Neuroimmunol (2017) 0.75

Transient global amnesia with a hippocampal lesion followed by transient epileptic amnesia. Seizure (2015) 0.75

Headache attributed to aeroplane travel and reversible cerebral vasoconstriction syndrome. Cephalalgia (2016) 0.75

Cryptococcosis mimicking lung cancer with brain metastasis. Clin Neurol Neurosurg (2015) 0.75

Recurrent, alternating orbital inflammation. J Neurol Sci (2015) 0.75